Clinical trials · San Francisco, CA
Chronic Inflammatory Demyelinating Polyneuropathy clinical trials in San Francisco
We’re tracking 5 recruiting chronic inflammatory demyelinating polyneuropathy studies with a site in or near San Francisco — including Phase 1, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near San Francisco
- NCT06798012RecruitingPhase 2
TAK-411 for adults with CIDP
This study tests a new investigational drug called TAK-411 for adults with chronic inflammatory demyelinating polyneuropathy (CIDP). It is for people who have already responded to immunoglobulin therapy and are on a stable dose.
San Francisco, CaliforniaAges 18 years+ - NCT07032662RecruitingPhase 2
Testing Imeroprubart for adults with CIDP
This trial tests a new drug called Imeroprubart for people with CIDP who are already on a stable treatment like steroids or immunoglobulin. The goal is to see if the drug can help control symptoms better.
San Francisco, CaliforniaAges 18 years+ - NCT06858579RecruitingPhase 3
Testing DNTH103 for chronic inflammatory demyelinating polyneuropathy (CIDP)
This trial tests a new drug called DNTH103 for adults with CIDP, a condition that affects nerves and causes weakness. It aims to see if the drug can help people who are currently on treatment, have tried treatment before, or are new to treatment.
San Francisco, CaliforniaAges 18–75 - NCT07304154RecruitingPhase 1
Study of KITE-363 for autoimmune nerve diseases
This trial tests a new treatment called KITE-363 for people with certain autoimmune nerve diseases, such as multiple sclerosis, myasthenia gravis, or chronic inflammatory demyelinating polyneuropathy, that have not responded well to standard therapies. The goal is to see if it is safe and effective.
Palo Alto, CaliforniaAges 18–75 - NCT06747351RecruitingPhase 3
Comparing two immune globulin treatments for CIDP
This study tests if TAK-881 is as safe and effective as HYQVIA for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). You may join if you have been stable on immune globulin therapy and have certain disability levels.
Palo Alto, CaliforniaAges 18 years+
Hear when a new Chronic Inflammatory Demyelinating Polyneuropathy trial opens near San Francisco, CA
We’ll email you when one opens near San Francisco, CA — at most once a week, no account needed, unsubscribe anytime.
Chronic Inflammatory Demyelinating Polyneuropathy trials in other cities
Where these studies are running near San Francisco
Institutions with a site for the recruiting chronic inflammatory demyelinating polyneuropathy studies listed above.
- Stanford Neuroscience Health Center · 2 studies
- Akero Clinical Study Site
- California Pacific Medical Center
- Site Number -1608
What taking part in a chronic inflammatory demyelinating polyneuropathy study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting chronic inflammatory demyelinating polyneuropathy studies in California.
Common questions
- Are there chronic inflammatory demyelinating polyneuropathy clinical trials near San Francisco?
- Yes. We're currently tracking 5 recruiting chronic inflammatory demyelinating polyneuropathy studies with a site near San Francisco, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a chronic inflammatory demyelinating polyneuropathy study near San Francisco?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in San Francisco to take part?
- Not necessarily. These studies have a site near San Francisco, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a chronic inflammatory demyelinating polyneuropathy trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New chronic inflammatory demyelinating polyneuropathy studies open near San Francisco regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.